Brought to you by:
The kids are alright
“I know I gotta get away and I know if I don’t, I’ll go out of my mind; better leave her behind with the kids, they’re alright, the kids are alright.” – Pete Townshend, The Who Mankind harnesses the power…
Dementia patients see worse outcomes after AAA repair
A cohort study using national Medicare data found patients with Alzheimer’s disease and related dementias face significantly higher risks across different outcomes after elective abdominal aortic aneurysm (AAA) repair. The data were presented at the 2026 annual meeting of the…
MDR certification secured for Impede embolization plug devices
Shape Memory Medical announced that its Impede embolization plug product family has received certification as a Class III device under the European Union (EU) Medical Device Regulation (MDR) 2017 The Impede devices, previously CE-marked under the Medical Device Directive 93/42/EEC…
NIH-funded WARRIORS trial advances toward launch
The National Institutes of Health (NIH) has approved funding for the WARRIORS international randomized trial comparing endovascular aneurysm repair (EVAR) with watchful waiting in women with small abdominal aortic aneurysms (AAAs) measuring 4–5.5 centimeters. In the United States, the trial…
ViTAA Medical announces FDA 510(k) clearance for aortic planning platform
ViTAA Medical today announced that the Food and Drug Administration (FDA) has granted 510(k) clearance for AiORTA Plan, which the company describes as a “fully automated, hyper-precise aortic surgery planning solution”. The tool aims to automate key preoperative measurements and…
Shape Memory Medical announces midway milestone in AAA-SHAPE randomised controlled pivotal trial
Shape Memory Medical has reached 50 per cent enrolment in its ongoing AAA-SHAPE pivotal trial, the company announced last week. AAA-SHAPE is a prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the Impede-FX RapidFill device to improve…
Randomized trial finds inferior mesenteric artery embolization ‘may not be effective’ in EVAR
Results from a multicenter randomized controlled trial (RCT) indicate that pre-emptive inferior mesenteric artery (IMA) embolisation during endovascular aneurysm repair (EVAR) does not significantly reduce aneurysm sac volume or rates of type II endoleak. The CLARIFY IMA study—which the authors…
‘Critical’ importance of lifelong surveillance after EVAR headlines newly published 10-year ENGAGE data
Ten-year data highlight the long-term efficacy and durability of the Endurant stent graft (Medtronic) in abdominal aortic aneurysm (AAA) patients who survived beyond five years post-enrollment in the ENGAGE registry. However, researchers also draw attention to the incidence of late…
VQI LEAF surveillance protocol set to be unveiled during VQI@VAM
Philip P. Goodney, MD, is unveiling a pivotal monitoring tool during the Vascular Quality Initiative (VQI) Annual Meeting, VQI@VAM, today—the Long-Term EVAR Assessment and Follow-up (LEAF) surveillance protocol, a multi-stakeholder initiative aimed at enhancing long-term monitoring of endovascular aneurysm repair…
CX 2025: EVAR founding fathers invoke revolutionary past to predict path ahead for aortic stent graft development
The next spring forward in aortic stent grafting will be rooted in a greater understanding of the biomechanical forces acting upon devices alongside continued advances and specialization in imaging, according to some of the founding fathers of endovascular aneurysm repair…